\-\ Texto\\:\\ \ \(0\)\
\-\ visual\\ symptoms\\:\ \(0\)\
\-\ decreased\\ vision\\ in\\ his\\ left\\ eye\\ to\\ hand\\ motions\\ \ \(0\)\
\-\ normal\\ vision\\,\\ right\\ eye\ \(0\)\
\-\ ophthalmic\\ examination\\:\ \(0\)\
\-\ large\\ yellow\\ choroidal\\ lesions\\ and\\ vitreous\\ cells\\,\\ left\\ eye\ \(0\)\
\-\ diagnostic\\ vitrectomy\\ performed\\ on\\ the\\ left\\ eye\\ in\\ september\\,\\ 2003\\.\\ specimen\\ sent\\ for\\ laser\\ scanning\\ cytometry\\:\\ \ \(0\)\
\-\ \\ \\-\\ \\‚\\Ä\\úmixed\\ population\\ of\\ t\\ and\\ b\\ lymphocytes\\ with\\ a\\ t\\:b\\ cell\\ ratio\\ of\\ 1\\:1\\‚\\Ä\\ù\ \(0\)\
\-\ \\ \\-\\ equal\\ populations\\ of\\ cd4\\+\\ and\\ cd8\\+\\ cells\ \(0\)\
\-\ \\ \\-\\ no\\ expression\\ of\\ cd5\\ or\\ cd10\ \(0\)\
\-\ \\ \\-\\ \\‚\\Ä\\úpolyclonal\\ expression\\ of\\ kappa\\ and\\ lambda\\‚\\Ä\\¶\\‚\\Ä\\ù\ \(1\)\
\-\ \\ \\-\\ cytologic\\ preparation\\ largely\\ inadequate\ \(0\)\
\-\ december\\,\\ 2003\\:\\ decreased\\ vision\\ in\\ the\\ right\\ eye\ \(0\)\
\-\ left\\ eye\\ was\\ blind\\ and\\ painful\\ leading\\ to\\ enucleation\\ of\\ the\\ left\\ eye\ \(0\)\
\-\ \\‚\\Ä\\¢\\ t2w\\ mr\\ shows\\ bilateral\\ frontal\\ lobe\\ involvement\\ from\\ a\\ \\"butterfly\\"\\ lesion\\ in\\ the\\ genu\\ of\\ the\\ corpus\\ callosum\ \(0\)\
\-\ \\‚\\Ä\\¢\\ enucleated\\ eye\\ \\-\\ after\\ vitrectomy\\ w\\/silicone\\ oil\\ replacement\\ \\-\\ shows\\ thickening\\ of\\ the\\ posterior\\ retina\\ w\\/small\\ round\\ blue\\ cells\ \(0\)\
\-\ retinal\\ lymphoma\\,\\ large\\ b\\-cell\\ type\ \(0\)\
\-\ \\‚\\Ä\\¢\\ \\"butterfly\\ lesions\\"\\ \\-\\ astrocytoma\\,\\ primary\\ cns\\ lymphoma\ \(0\)\
\-\ \\‚\\Ä\\¢\\ retinal\\ \\"blue\\ cell\\ tumor\\"\ \(0\)\
\-\ \\ \\-\\ retinal\\ lymphoma\ \(0\)\
\-\ \\ \\-\\ retinoblastoma\ \(0\)\
\-\ \\ \\-\\ chronic\\ \\(benign\\)\\ choroidal\\ inflammation\ \(0\)\
\-\ \\‚\\Ä\\¢\\ status\\-post\\ vitrectomy\ \(0\)\
\-\ \\ \\-\\ intraocular\\ silicone\\ oil\ \(0\)\
\-\ \\ \\-\\ cataract\ \(0\)\
\-\ \\ \\-\\ angle\\ closure\\ glaucoma\ \(0\)\
\-\ 62\\ y\\.o\\.\\ man\\ c\\/o\\ progressive\\ visual\\ problem\\ in\\ his\\ left\\ eye\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ eye\\:\\ 0\\.4656058479115505\ \(0\)\
\-\ vitrectomy\\:\\ 0\\.2790955354672702\ \(0\)\
\-\ retinal\\:\\ 0\\.22719404627925155\ \(0\)\
\-\ expression\\:\\ 0\\.1681866255005415\ \(0\)\
\-\ vision\\:\\ 0\\.1680263852921396\ \(0\)\
\-\ butterfly\\:\\ 0\\.1627186446858644\ \(0\)\
\-\ oil\\:\\ 0\\.16115433683984787\ \(0\)\
\-\ choroidal\\:\\ 0\\.15702047437487324\ \(0\)\
\-\ cells\\:\\ 0\\.14947933861135698\ \(0\)\
\-\ silicone\\:\\ 0\\.14782717315070995\ \(0\)\
\-\ blue\\:\\ 0\\.14700259243836208\ \(0\)\
\-\ left\\:\\ 0\\.13235975792980367\ \(0\)\
\-\ 2003\\:\\ 0\\.11639506865570537\ \(0\)\
\-\ lymphoma\\:\\ 0\\.11554293695262745\ \(0\)\
\-\ cell\\:\\ 0\\.11098070755772492\ \(0\)\
\-\ visual\\:\\ 0\\.1103496714876816\ \(0\)\
\-\ of\\:\\ 0\\.10124328227267919\ \(0\)\
\-\ polyclonal\\:\\ 0\\.09882294004702057\ \(0\)\
\-\ enucleated\\:\\ 0\\.09882294004702057\ \(0\)\
\-\ cd5\\:\\ 0\\.09303184515575673\ \(0\)\
\-\ kappa\\:\\ 0\\.09303184515575673\ \(0\)\
\-\ cd10\\:\\ 0\\.08921734846668333\ \(0\)\
\-\ cytometry\\:\\ 0\\.08770353841159992\ \(0\)\
\-\ cytologic\\:\\ 0\\.08770353841159992\ \(0\)\
\-\ vitreous\\:\\ 0\\.08517381903200558\ \(0\)\
\-\ cataract\\:\\ 0\\.08517381903200558\ \(0\)\
\-\ intraocular\\:\\ 0\\.08409331275027075\ \(0\)\
\-\ motions\\:\\ 0\\.08310688779951826\ \(0\)\
\-\ preparation\\:\\ 0\\.08310688779951826\ \(0\)\
\-\ genu\\:\\ 0\\.08310688779951826\ \(0\)\
\-\ glaucoma\\:\\ 0\\.08310688779951826\ \(0\)\
\-\ populations\\:\\ 0\\.08219946480833432\ \(0\)\
\-\ in\\:\\ 0\\.0804375719282651\ \(0\)\
\-\ decreased\\:\\ 0\\.0801144429284212\ \(0\)\
\-\ retina\\:\\ 0\\.07984551228784877\ \(0\)\
\-\ laser\\:\\ 0\\.0791582269964461\ \(0\)\
\-\ december\\:\\ 0\\.07851023718743662\ \(0\)\
\-\ his\\:\\ 0\\.07844021313736177\ \(0\)\
\-\ the\\:\\ 0\\.07742268874204376\ \(0\)\
\-\ enucleation\\:\\ 0\\.07731579290825444\ \(0\)\
\-\ retinoblastoma\\:\\ 0\\.07731579290825444\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.07676267173085054\ \(0\)\
\-\ shows\\:\\ 0\\.07591005639215638\ \(0\)\
\-\ september\\:\\ 0\\.07524886167576712\ \(0\)\
\-\ inadequate\\:\\ 0\\.07524886167576712\ \(0\)\
\-\ lesions\\:\\ 0\\.07428012340440797\ \(0\)\
\-\ largely\\:\\ 0\\.07391358657535498\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.07271914229617278\ \(0\)\
\-\ yellow\\:\\ 0\\.07097157683958671\ \(0\)\
\-\ scanning\\:\\ 0\\.07034159614527773\ \(0\)\
\-\ specimen\\:\\ 0\\.0689046456070994\ \(0\)\
\-\ closure\\:\\ 0\\.06837726050276846\ \(0\)\
\-\ blind\\:\\ 0\\.06812249168409114\ \(0\)\
\-\ and\\:\\ 0\\.06681514417901604\ \(0\)\
\-\ t2w\\:\\ 0\\.06524544909070315\ \(0\)\
\-\ ratio\\:\\ 0\\.06486111617242164\ \(0\)\
\-\ large\\:\\ 0\\.0648046212004796\ \(0\)\
\-\ problem\\:\\ 0\\.06378060989068682\ \(0\)\
\-\ equal\\:\\ 0\\.06188676194875038\ \(0\)\
\-\ 62\\:\\ 0\\.061599740660752134\ \(0\)\
\-\ population\\:\\ 0\\.06118239039138556\ \(0\)\
\-\ callosum\\:\\ 0\\.06091245536934947\ \(0\)\
\-\ sent\\:\\ 0\\.060519234379017316\ \(0\)\
\-\ cns\\:\\ 0\\.06039113431187075\ \(0\)\
\-\ corpus\\:\\ 0\\.05895721701392989\ \(0\)\
\-\ replacement\\:\\ 0\\.05809304754839324\ \(0\)\
\-\ leading\\:\\ 0\\.057485577132653884\ \(0\)\
\-\ painful\\:\\ 0\\.05719362790051375\ \(0\)\
\-\ angle\\:\\ 0\\.05672315643537633\ \(0\)\
\-\ mixed\\:\\ 0\\.053531118970559996\ \(0\)\
\-\ round\\:\\ 0\\.05298793793874682\ \(0\)\
\-\ inflammation\\:\\ 0\\.0519739229638635\ \(0\)\
\-\ hand\\:\\ 0\\.0505514159686249\ \(0\)\
\-\ progressive\\:\\ 0\\.04952939684320086\ \(0\)\
\-\ diagnostic\\:\\ 0\\.04928766624944533\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.048819139435893374\ \(0\)\
\-\ involvement\\:\\ 0\\.04680588239716827\ \(0\)\
\-\ benign\\:\\ 0\\.044423144244662004\ \(0\)\
\-\ thickening\\:\\ 0\\.04399529213543381\ \(0\)\
\-\ type\\:\\ 0\\.043382346358409596\ \(0\)\
\-\ right\\:\\ 0\\.04288080773744566\ \(0\)\
\-\ mr\\:\\ 0\\.04184370226202644\ \(0\)\
\-\ frontal\\:\\ 0\\.04162261049236705\ \(0\)\
\-\ examination\\:\\ 0\\.041381906432773785\ \(0\)\
\-\ primary\\:\\ 0\\.03976437437951228\ \(0\)\
\-\ chronic\\:\\ 0\\.03838558887904282\ \(0\)\
\-\ performed\\:\\ 0\\.038258310641997015\ \(0\)\
\-\ lobe\\:\\ 0\\.03737176946795288\ \(0\)\
\-\ symptoms\\:\\ 0\\.03538313864267644\ \(0\)\
\-\ bilateral\\:\\ 0\\.0347554334112567\ \(0\)\
\-\ man\\:\\ 0\\.034236499097715825\ \(0\)\
\-\ tumor\\:\\ 0\\.033825567492106225\ \(0\)\
\-\ posterior\\:\\ 0\\.03344082693155574\ \(0\)\
\-\ to\\:\\ 0\\.03233417752612324\ \(0\)\
\-\ after\\:\\ 0\\.031371925634710376\ \(0\)\
\-\ lesion\\:\\ 0\\.03100369160281007\ \(0\)\
\-\ normal\\:\\ 0\\.026403863209258447\ \(0\)\
\-\ from\\:\\ 0\\.025683730775551125\ \(0\)\
\-\ was\\:\\ 0\\.022537739066023504\ \(0\)\
\-\ or\\:\\ 0\\.022497145977942355\ \(0\)\
\-\ no\\:\\ 0\\.021029578453086152\ \(0\)\
\-\ for\\:\\ 0\\.01960063611358115\ \(0\)\
\-\ on\\:\\ 0\\.01953110670017523\ \(0\)\
\-\ with\\:\\ 0\\.012662971888714023\ \(0\)\
